Biogen Inc (BIIB)
Financial leverage ratio
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total assets | US$ in thousands | 28,049,300 | 28,313,200 | 26,804,100 | 26,567,600 | 26,844,800 | 28,193,200 | 25,156,800 | 24,598,400 | 24,554,100 | 24,854,200 | 25,081,400 | 23,614,400 | 23,877,300 | 23,806,700 | 24,470,400 | 23,854,700 | 24,618,900 | 24,934,100 | 25,511,800 | 26,119,200 |
Total stockholders’ equity | US$ in thousands | 16,716,000 | 16,358,900 | 15,889,100 | 15,213,000 | 14,799,400 | 14,483,800 | 14,466,900 | 13,796,600 | 13,397,900 | 12,775,500 | 11,872,500 | 11,242,300 | 10,896,200 | 10,429,900 | 10,751,900 | 10,682,200 | 10,700,300 | 10,758,500 | 11,308,700 | 12,546,900 |
Financial leverage ratio | 1.68 | 1.73 | 1.69 | 1.75 | 1.81 | 1.95 | 1.74 | 1.78 | 1.83 | 1.95 | 2.11 | 2.10 | 2.19 | 2.28 | 2.28 | 2.23 | 2.30 | 2.32 | 2.26 | 2.08 |
December 31, 2024 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $28,049,300K ÷ $16,716,000K
= 1.68
The financial leverage ratio of Biogen Inc has been gradually declining from 2.08 as of March 31, 2020, to 1.68 as of December 31, 2024. This suggests that the company has been reducing its reliance on debt to finance its operations and investments over this period. A decreasing trend in the financial leverage ratio indicates improved financial stability and lower financial risk for the company. It shows that Biogen Inc has been effectively managing its debt levels and capital structure, which can enhance its overall financial health and resilience in challenging economic conditions. Additionally, a lower financial leverage ratio may also signal greater flexibility for the company in terms of future strategic decisions and expansion opportunities, as it has lower debt obligations to service. Overall, the declining trend in Biogen Inc's financial leverage ratio reflects a positive trajectory in its financial management and risk mitigation strategies.
Peer comparison
Dec 31, 2024